Diabetes

With FDA approval of more than 20 new therapies for diabetes since 2010, clinicians and patients are often overwhelmed with treatment choices.

A team-based approach to diabetes patient care can help improve outcomes, according to a Pharmacy Times® Peer Exchange that addressed this subject recently.

Officials with the FDA have approved Medtronic’s continuous glucose monitoring (CGM) system (Guardian Connect) for use by individuals living with diabetes, according to a company press release.

The Guardian Connect System can alert patients of potential high or low glucose events up to an hour in advance.

ADA urges health care providers to continue to develop personalized care plans that can yield optimal short and long-term results for each individual with diabetes.

Many small health start-ups are leveraging digital health and telemedicine services to provide patient coaching. A new study from one company demonstrates that users could see as much as a 0.8% reduction in A1c.

The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.

Clinicians should personalize patient's goals for blood sugar control in type 2 diabetes.

With new smartphones able to measure blood pressure, what does this mean for other companies who solely make these devices?

Proposed federal legislation aims to achieve better health outcomes by giving patients with diabetes the freedom to decide which testing supplies work best for them.

Through clinical and humanistic interventions, pharmacists can improve outcomes and lower costs for patients with diabetes.

Value-based contracts may also improve patient outcomes by increasing access to innovative medicines and supporting appropriate use.

As cost increases, patient adherence decreases among patients with multiple chronic conditions.

The latest DrugStats database list shows the medications with increasing numbers of prescriptions.

Diabetes is a chronic condition characterized by hyperglycemia, because of reduced insulin secretion from the pancreas and/or insulin resistance.

Bone fractures associated with type 2 diabetes may be linked to a change in collagen.

Adults over the age of 65 are increasingly more active on Facebook, especially when it comes to health information.

Evaluating medical and pharmacy benefits can provide a better view of a medication's value.

Diabetes treatment guidelines treating patients until they reach blood pressure target goals.

Actual target blood pressures differ between guidelines.

Shadow pricing of diabetes medications is among the key issues confronting patients managing this chronic disease.

Diabetes Self-Management Education and Support (DSMES) is increasingly important as the number of Americans who have diabetes approaches 31 million.

Diabetes is the seventh-leading cause of death in the United States.